Cargando…

Elimination of SOX2/OCT4-Associated Prostate Cancer Stem Cells Blocks Tumor Development and Enhances Therapeutic Response

SOX2 and OCT4 are key regulators of embryonic stem cell pluripotency. They are overexpressed in prostate cancers and have been associated with cancer stem cell (CSC) properties. However, reliable tools for detecting and targeting SOX2/OCT4-overexpressing cells are lacking, limiting our understanding...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaddi, Prasanna Kumar, Stamnes, Mark A., Cao, Huojun, Chen, Songhai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769476/ https://www.ncbi.nlm.nih.gov/pubmed/31500347 http://dx.doi.org/10.3390/cancers11091331

Ejemplares similares

Inhibiting G protein βγ signaling blocks prostate cancer progression and enhances the efficacy of paclitaxel
por: Paudyal, Prakash, et al.
Publicado: (2017)

Deciphering the Sox-Oct partner code by quantitative cooperativity measurements
por: Ng, Calista K. L., et al.
Publicado: (2012)

Expression of SOX2 and OCT4 in odontogenic cysts and tumors
por: Phattarataratip, Ekarat, et al.
Publicado: (2021)

SOX2 in cancer stemness: tumor malignancy and therapeutic potentials
por: Mamun, Mahfuz Al, et al.
Publicado: (2018)

Immunoexpression of stem cell markers SOX-2, NANOG AND OCT4 in ameloblastoma
por: Martins Balbinot, Karolyny, et al.
Publicado: (2023)

Enhanced proliferation and differentiation of Oct4- and Sox2-overexpressing human adipose tissue mesenchymal stem cells
por: Han, Sei-Myoung, et al.
Publicado: (2014)

The dyskerin ribonucleoprotein complex as an OCT4/SOX2 coactivator in embryonic stem cells
por: Fong, Yick W, et al.
Publicado: (2014)

Enhanced Hepatogenic Transdifferentiation of Human Adipose Tissue Mesenchymal Stem Cells by Gene Engineering with Oct4 and Sox2
por: Han, Sei-Myoung, et al.
Publicado: (2015)

Enhanced expression of the stemness-related factors OCT4, SOX15 and TWIST1 in ectopic endometrium of endometriosis patients
por: Proestling, Katharina, et al.
Publicado: (2016)

Enhanced OCT4 transcriptional activity substitutes for exogenous SOX2 in cellular reprogramming
por: Marthaler, Adele G., et al.
Publicado: (2016)

Characterization of SOX2, OCT4 and NANOG in Ovarian Cancer Tumor-Initiating Cells
por: Robinson, Mikella, et al.
Publicado: (2021)

Correction: Enhanced Hepatogenic Transdifferentiation of Human Adipose Tissue Mesenchymal Stem Cells by Gene Engineering with Oct4 and Sox2
por: Han, Sei-Myoung, et al.
Publicado: (2017)

Enrichment of the embryonic stem cell reprogramming factors Oct4, Nanog, Myc, and Sox2 in benign and malignant vascular tumors
por: Amaya, Clarissa N., et al.
Publicado: (2015)

Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate
por: Stefanovic, Sonia, et al.
Publicado: (2009)

SOX2, OCT4 and NANOG: The core embryonic stem cell pluripotency regulators in oral carcinogenesis
por: Swain, Niharika, et al.
Publicado: (2020)

Targeting of replicating CD133 and OCT4/SOX2 expressing glioma stem cells selects a cell population that reinitiates tumors upon release of therapeutic pressure
por: Guerra-Rebollo, Marta, et al.
Publicado: (2019)

Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes(†)
por: Boer, Brian, et al.
Publicado: (2007)

Blocking Gi/o-Coupled Signaling Eradicates Cancer Stem Cells and Sensitizes Breast Tumors to HER2-Targeted Therapies to Inhibit Tumor Relapse
por: Lyu, Cancan, et al.
Publicado: (2022)

Transcriptional Regulation of Vih by Oct4 and Sox9 in Scylla paramamosain
por: Liao, Jiaqian, et al.
Publicado: (2020)

Exogenous OCT4 and SOX2 Contribution to In Vitro Reprogramming in Cattle
por: Machado, Lucas Simões, et al.
Publicado: (2023)

Differential Nucleosome Occupancies across Oct4-Sox2 Binding Sites in Murine Embryonic Stem Cells
por: Sebeson, Amy, et al.
Publicado: (2015)

Bufalin attenuates triple-negative breast cancer cell stemness by inhibiting the expression of SOX2/OCT4
por: Chen, Fei, et al.
Publicado: (2020)

Dissecting the role of distinct OCT4-SOX2 heterodimer configurations in pluripotency
por: Tapia, Natalia, et al.
Publicado: (2015)

Clinical significance of OCT4 and SOX2 protein expression in cervical cancer
por: Kim, Bo Wook, et al.
Publicado: (2015)

Phosphorylation of Threonine(343) Is Crucial for OCT4 Interaction with SOX2 in the Maintenance of Mouse Embryonic Stem Cell Pluripotency
por: Abulaiti, Xianmixinuer, et al.
Publicado: (2017)

Expression of OCT-4 and SOX-2 in Bone Marrow-Derived Human Mesenchymal Stem Cells during Osteogenic Differentiation
por: Matic, Igor, et al.
Publicado: (2016)

Dynamical reorganization of the pluripotency transcription factors Oct4 and Sox2 during early differentiation of embryonic stem cells
por: Verneri, Paula, et al.
Publicado: (2020)

Embryonic Stem Cells Markers SOX2, OCT4 and Nanog Expression and Their Correlations with Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma
por: Luo, Weiren, et al.
Publicado: (2013)

Alanine–Glyoxylate Aminotransferase Sustains Cancer Stemness Properties through the Upregulation of SOX2 and OCT4 in Hepatocellular Carcinoma Cells
por: Ye, Peng, et al.
Publicado: (2022)

Expression and Functional Analysis of core stemness factors OSKM (OCT4, SOX2, KLF4, and MYC) in Pan-cancer
por: Hong, Liwei, et al.
Publicado: (2023)

Differential Expression of ID4 and Its Association with TP53 Mutation, SOX2, SOX4 and OCT-4 Expression Levels
por: Galatro, Thais Fernanda de Almeida, et al.
Publicado: (2013)

Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma
por: Ge, Nan, et al.
Publicado: (2010)

Negative reciprocity, not ordered assembly, underlies the interaction of Sox2 and Oct4 on DNA
por: Biddle, John W, et al.
Publicado: (2019)

Endogenous fluctuations of OCT4 and SOX2 bias pluripotent cell fate decisions
por: Strebinger, Daniel, et al.
Publicado: (2019)

Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue
por: Baghai Naini, Fereshteh, et al.
Publicado: (2019)

Correction: Embryonic Stem Cells Markers SOX2, OCT4 and Nanog Expression and Their Correlations with Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma
por: Luo, Weiren, et al.
Publicado: (2013)

Gene expression of OCT4, SOX2, KLF4 and MYC (OSKM) induced pluripotent stem cells: identification for potential mechanisms
por: Cai, Yanning, et al.
Publicado: (2015)

Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer
por: You, Liuping, et al.
Publicado: (2018)

Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication
por: Kaufhold, Samantha, et al.
Publicado: (2016)

Ddx56 maintains proliferation of mouse embryonic stem cells via ribosome assembly and interaction with the Oct4/Sox2 complex
por: Wang, Jingwen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2majddkjl38bff4jh7q991hqbh